GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Newron Pharmaceuticals SpA (XTER:NP5) » Definitions » Other Current Liabilities

Newron Pharmaceuticals SpA (XTER:NP5) Other Current Liabilities : €3.52 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Newron Pharmaceuticals SpA Other Current Liabilities?

Newron Pharmaceuticals SpA's other current liabilities for the quarter that ended in Dec. 2023 was €3.52 Mil.

Newron Pharmaceuticals SpA's quarterly other current liabilities declined from Dec. 2022 (€1.77 Mil) to Jun. 2023 (€1.40 Mil) but then increased from Jun. 2023 (€1.40 Mil) to Dec. 2023 (€3.52 Mil).

Newron Pharmaceuticals SpA's annual other current liabilities increased from Dec. 2021 (€0.73 Mil) to Dec. 2022 (€1.77 Mil) and increased from Dec. 2022 (€1.77 Mil) to Dec. 2023 (€3.52 Mil).


Newron Pharmaceuticals SpA Other Current Liabilities Historical Data

The historical data trend for Newron Pharmaceuticals SpA's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Newron Pharmaceuticals SpA Other Current Liabilities Chart

Newron Pharmaceuticals SpA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Newron Pharmaceuticals SpA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Newron Pharmaceuticals SpA Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Newron Pharmaceuticals SpA Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Newron Pharmaceuticals SpA's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Newron Pharmaceuticals SpA (XTER:NP5) Business Description

Traded in Other Exchanges
Address
Via Antonio Meucci 3, Bresso, Milan, ITA, 20091
Newron Pharmaceuticals SpA is a biopharmaceutical company focused on the development of therapies for patients with diseases of the central and peripheral nervous system. Geographically the research and development activities are performed in Italy and the United States.

Newron Pharmaceuticals SpA (XTER:NP5) Headlines

No Headlines